BALMER LAWRIE INVESTMENTS
|
|
BOM : 532485     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Nov 22,2024 |
Price(EOD): ₹ 75.11
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Finance - NBFC |
MCap: ₹ 1,667.44 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
BALMER LAWRIE INVESTMENTS | -2.5% | -0.2% | 73.1% |
BAJAJ FINANCE | 2% | 0.1% | -10.5% |
BAJAJ HOLDINGS & INVESTMENT | -3.6% | 1.7% | 41.8% |
CHOLAMANDALAM INVESTMENT AND FINANCE COMPANY | 0.3% | -14.3% | 7% |
SHRIRAM FINANCE | 1% | -12.2% | 40.5% |
SBI CARDS AND PAYMENT SERVICES | -0.5% | -3.5% | -7.8% |
MUTHOOT FINANCE | 8.4% | 0.8% | 41.9% |
ADITYA BIRLA CAPITAL | -1.2% | -10.3% | 7% |
SUNDARAM FINANCE | 0.3% | -15.3% | 25.6% |
FUNDAMENTAL ANALYSIS OF BALMER LAWRIE INVESTMENTS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF BALMER LAWRIE INVESTMENTS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
8.12
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 205.23 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] 1.37
P/B Calculated based on Book Value of Rs 1,220.78 Cr
[Latest Year - Mar2024 - Consolidated Results ] 0.68
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,448.58 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-27% 44% 14% |
SHARE PRICE MOMENTUM OF BALMER LAWRIE INVESTMENTS
BALMER LAWRIE INVESTMENTS vs SENSEX
DEBT OF BALMER LAWRIE INVESTMENTS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0 0 - |
0.06 0.08 0.08 0.07 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF BALMER LAWRIE INVESTMENTS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF BALMER LAWRIE INVESTMENTS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
0.14% 9.48% 11.61% -2.45% |
9.21% -5.24% -7.88% -7.36% |
QtrlyTrend |
0 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
BALMER LAWRIE INVESTMENTS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
S&P BSE FINANCE | -1.6% | -3.8% | 15.9% |
S&P BSE MIDSMALLCAP | -2.3% | -7.5% | 33.6% |
S&P BSE SMALL CAP | -2.7% | -7.7% | 32.8% |
You may also like the below Video Courses
FAQ about BALMER LAWRIE INVESTMENTS
Is BALMER LAWRIE INVESTMENTS good for long term investment?
As on Nov 22,2024, the Fundamentals of BALMER LAWRIE INVESTMENTS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of BALMER LAWRIE INVESTMENTS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is BALMER LAWRIE INVESTMENTS UnderValued or OverValued?
As on Nov 22,2024, BALMER LAWRIE INVESTMENTS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of BALMER LAWRIE INVESTMENTS ?
As on Nov 22,2024, the Intrinsic Value of BALMER LAWRIE INVESTMENTS is Rs. 65.95 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 103.35
Fair Value [Median EV / Sales Model] : Rs. 52.05
Fair Value [Median Price / Sales Model] : Rs. 65.95
Estimated Median Fair Value of BALMER LAWRIE INVESTMENTS : Rs. 65.95
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.